Drug- and toxin-associated seizures

Medical Clinics of North America

Volumn 89, Issue 6, 2005, Pages 1297-1321

  Wills, Brandon ^a,b,c   Erickson, Timothy ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Toxikon Consortium   (United States)

^c Section of Clinical Toxicology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMFEBUTAMONE; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CENTRAL STIMULANT AGENT; DIAZEPAM; DIPHENHYDRAMINE; EDETIC ACID; FERRIC FERROCYANIDE; GLUCOSE; GLUTAMIC ACID; GLYCINE; ISONIAZID; LORAZEPAM; MIDAZOLAM; OCTREOTIDE; PHENOBARBITAL; PHENYTOIN; PRALIDOXIME; PROPOFOL; PYRIDOXINE; THEOPHYLLINE; TRAMADOL; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; DRUG OVERDOSE; ENVENOMATION; EXPOSURE; HEALTH SURVEY; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPOTENSION; INCIDENCE; METABOLIC DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QRS COMPLEX; REVIEW; SEIZURE; TOXICITY; TOXICOLOGY;

HUMANS; PHARMACEUTICAL PREPARATIONS; SEIZURES; TOXINS, BIOLOGICAL;

EID: 26844549162     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2005.06.004     Document Type: Review

References (163)

1. American Association of Poison Control Centers. Toxic Exposure Surveillance System. Available at: http://www.aapcc.org. Accessed November 2004.
2. R.J. DeLorenzo, W.A. Hauser, and A.R. Towne A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia Neurology 46 4 1996 1029 1035
3. K.R. Olson, T.E. Kearney, and J.E. Dyer Seizures associated with poisoning and drug overdose Am J Emerg Med 12 3 1994 392 395
4. J.G.K.T. Thundiyil, and K.R. Olson Evolving epidemiology of drug-induced seizures reported to a poison control center system J Toxicol Clin Toxicol 42 5 2004 730
5. D.H. Lowenstein, T. Bleck, and R.L. Macdonald It's time to revise the definition of status epilepticus Epilepsia 40 1 1999 120 122
6. P.E. Marik, and J. Varon The management of status epilepticus Chest 126 2 2004 582 591
7. W. Loscher Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy Prog Neurobiol 54 6 1998 721 741
8. N.B. Fountain, and E.W. Lothman Pathophysiology of status epilepticus J Clin Neurophysiol 12 4 1995 326 342
9. P.G. Cohen The metabolic basis for the genesis of seizures: the role of the potassium-ammonia axis Med Hypotheses 13 3 1984 311 316
10. J.E. Dyer, B. Roth, and B.A. Hyma Gamma-hydroxybutyrate withdrawal syndrome Ann Emerg Med 37 2 2001 147 153
11. K. Morimoto, M. Fahnestock, and R.J. Racine Kindling and status epilepticus models of epilepsy: rewiring the brain Prog Neurobiol 73 1 2004 1 60
12. J.S. Teitelbaum, R.J. Zatorre, and S. Carpenter Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels N Engl J Med 322 25 1990 1781 1787
13. S. Shadnia, M. Moiensadat, and M. Abdollahi A case of acute strychnine poisoning Vet Hum Toxicol 46 2 2004 76 79
14. I.A. Walker, and C.M. Slovis Lidocaine in the treatment of status epilepticus Acad Emerg Med 4 9 1997 918 922
15. R.J. Marley, J.M. Witkin, and S.R. Goldberg A pharmacogenetic evaluation of the role of local anesthetic actions in the cocaine kindling process Brain Res 562 2 1991 251 257
16. R.W. Derlet, T.E. Albertson, and R.S. Tharratt Lidocaine potentiation of cocaine toxicity Ann Emerg Med 20 2 1991 135 138
17. M. Linnoila, I. Mefford, and D. Nutt NIH conference. Alcohol withdrawal and noradrenergic function Ann Intern Med 107 6 1987 875 889
18. K. Tuovinen Organophosphate-induced convulsions and prevention of neuropathological damages Toxicology 196 1-2 2004 31 39
19. B.B. Fredholm, A.P. IJzerman, and K.A. Jacobson International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 4 2001 527 552
20. L.A. Etherington, and B.G. Frenguelli Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner Eur J Neurosci 19 9 2004 2539 2550
21. H. Yokoyama, M. Sato, and K. Iinuma Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats Neurosci Lett 217 2-3 1996 194 196
22. C. Kamei, M. Ohuchi, and Y. Sugimoto Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats Brain Res 887 1 2000 183 186
23. N. Delanty, C.J. Vaughan, and J.A. French Medical causes of seizures Lancet 352 9125 1998 383 390
24. J.R. Carbone The neuroleptic malignant and serotonin syndromes Emerg Med Clin North Am 18 2 2000 317 325 x
25. B. Knight, N. Thomson, and G. Perry Seizures due to norpethidine toxicity Aust N Z J Med 30 4 2000 513
26. P.J. Armstrong, and A. Bersten Normeperidine toxicity Anesth Analg 65 5 1986 536 538
27. H.A. Spiller, S.E. Gorman, and D. Villalobos Prospective multicenter evaluation of tramadol exposure J Toxicol Clin Toxicol 35 4 1997 361 364
28. P. Sloth Madsen, J. Strom, and S. Reiz Acute propoxyphene self-poisoning in 222 consecutive patients Acta Anaesthesiol Scand 28 6 1984 661 665
29. B.K. Alldredge, D.H. Lowenstein, and R.P. Simon Seizures associated with recreational drug abuse Neurology 39 8 1989 1037 1039
30. W.H. Spivey, and B. Euerle Neurologic complications of cocaine abuse Ann Emerg Med 19 12 1990 1422 1428
31. K.A. Graeme New drugs of abuse Emerg Med Clin North Am 18 4 2000 625 636
32. T.E. Freese, K. Miotto, and C.J. Reback The effects and consequences of selected club drugs J Subst Abuse Treat 23 2 2002 151 156
33. B.S. Koppel, L. Samkoff, and M. Daras Relation of cocaine use to seizures and epilepsy Epilepsia 37 9 1996 875 878
34. L.E. O'Dell, M.J. Kreifeldt, and F.R. George The role of serotonin(2) receptors in mediating cocaine-induced convulsions Pharmacol Biochem Behav 65 4 2000 677 681
35. I.C.M.S. Yao, K. O'Koren, and M.A. Guffey Delayed onset of seizure in a body stuffer J Toxicol Clin Toxicol 41 5 2003 650
36. P.E. Mason, and W.P. Kerns II Gamma hydroxybutyric acid (GHB) intoxication Acad Emerg Med 9 7 2002 730 739
37. R.Q. Hu, M.A. Cortez, and H.Y. Man Gamma-hydroxybutyric acid-induced absence seizures in GluR2 null mutant mice Brain Res 897 1-2 2001 27 35
38. R.Q. Hu, M.A. Cortez, and H.Y. Man Alteration of GLUR2 expression in the rat brain following absence seizures induced by gamma-hydroxybutyric acid Epilepsy Res 44 1 2001 41 51
39. K. Craig, H.F. Gomez, and J.L. McManus Severe gamma-hydroxybutyrate withdrawal: a case report and literature review J Emerg Med 18 1 2000 65 70
40. M.B. Mycyk, C. Wilemon, and S.E. Aks Two cases of withdrawal from 1,4-Butanediol use Ann Emerg Med 38 3 2001 345 346
41. M. McDonough, N. Kennedy, and A. Glasper Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review Drug Alcohol Depend 75 1 2004 3 9
42. T.C. Bania, T. Ashar, and G. Press Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model Acad Emerg Med 10 7 2003 697 704
43. C.H. Barton, M.L. Sterling, and N.D. Vaziri Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay Ann Emerg Med 10 5 1981 243 246
44. M.M. McCarron, B.W. Schulze, and G.A. Thompson Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases Ann Emerg Med 10 5 1981 237 242
45. L. Vieira, and A. Weiner Ketamine abusers presenting to the emergency department: a case series J Toxicol Clin Toxicol 36 5 1998 505
46. D.J. Borris, E.H. Bertram, and J. Kapur Ketamine controls prolonged status epilepticus Epilepsy Res 42 2-3 2000 117 122
47. L.D. Mewasingh, T. Sekhara, and A. Aeby Oral ketamine in paediatric non-convulsive status epilepticus Seizure 12 7 2003 483 489
48. H.F.H. Isbell, A. Wikler, and R.E. Belleville An experimental study of the etiology of "rum fits" and delirium tremens Q J Stud Alcohol 16 1955 1 33
49. M. Victor, and R.D. Adams The effect of alcohol on the nervous system Res Publ Assoc Res Nerv Ment Dis 32 1953 526 573
50. K.B. Nolop, and A. Natow Unprecedented sedative requirements during delirium tremens Crit Care Med 13 4 1985 246 247
51. W.C. Lineaweaver, K. Anderson, and D.N. Hing Massive doses of midazolam infusion for delirium tremens without respiratory depression Crit Care Med 16 3 1988 294 295
52. T.R. Coomes, and S.W. Smith Successful use of propofol in refractory delirium tremens Ann Emerg Med 30 6 1997 825 828
53. C. McCowan, and P. Marik Refractory delirium tremens treated with propofol: a case series Crit Care Med 28 6 2000 1781 1784
54. G.P. Young, C. Rores, and C. Murphy Intravenous phenobarbital for alcohol withdrawal and convulsions Ann Emerg Med 16 8 1987 847 850
55. H. Petursson The benzodiazepine withdrawal syndrome Addiction 89 11 1994 1455 1459
56. W.H. Spivey Flumazenil and seizures: analysis of 43 cases Clin Ther 14 2 1992 292 305
57. D.L. Seger Flumazenil - treatment or toxin J Toxicol Clin Toxicol 42 2 2004 209 216
58. M.I. Greenberg, and R.G. Hendrickson Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement J Toxicol Clin Toxicol 41 1 2003 83 85
59. L.B. Green, and V.S. Nelson Death after acute withdrawal of intrathecal baclofen: case report and literature review Arch Phys Med Rehabil 80 12 1999 1600 1604
60. C.T. Peng, J. Ger, and C.C. Yang Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose J Toxicol Clin Toxicol 36 4 1998 359 363
61. M. Kofler, and A. Arturo Leis Prolonged seizure activity after baclofen withdrawal Neurology 42 3 Pt 1 1992 697 698
62. A. Khorasani, and W.T. Peruzzi Dantrolene treatment for abrupt intrathecal baclofen withdrawal Anesth Analg 80 5 1995 1054 1056
63. L. Pimentel, and L. Trommer Cyclic antidepressant overdoses. A review Emerg Med Clin North Am 12 2 1994 533 547
64. D.A. Frommer, K.W. Kulig, and J.A. Marx Tricyclic antidepressant overdose. A review JAMA 257 4 1987 521 526
65. B.A. Hulten, R. Adams, and R. Askenasi Predicting severity of tricyclic antidepressant overdose J Toxicol Clin Toxicol 30 2 1992 161 170
66. C.L. Emerman, A.F. Connors Jr., and G.M. Burma Level of consciousness as a predictor of complications following tricyclic overdose Ann Emerg Med 16 3 1987 326 330
67. B. Bailey, N.A. Buckley, and D.K.A. Amre Meta-analysis of prognostic indicators to predict seizures, arrhythmias or death after tricyclic antidepressant overdose J Toxicol Clin Toxicol 42 6 2004 877 888
68. J.L. McCabe, D.J. Cobaugh, and J.J. Menegazzi Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation Ann Emerg Med 32 3 Pt 1 1998 329 333
69. M. Callaham, H. Schumaker, and P. Pentel Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning J Pharmacol Exp Ther 245 1 1988 216 220
70. G.K. Isbister, S.J. Bowe, and A. Dawson Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose J Toxicol Clin Toxicol 42 3 2004 277 285
71. G.V. Raju, T.C. Kumar, and S. Khanna Seizures associated with sertraline Can J Psychiatry 45 5 2000 491
72. C.A. Kelly, N. Dhaun, and W.J. Laing Comparative toxicity of citalopram and the newer antidepressants after overdose J Toxicol Clin Toxicol 42 1 2004 67 71
73. M.A. Fuller Drug information handbook for psychiatry 3rd edition 2002 Lexi-Comp Husdon (OH)
74. M.G. Belson, and T.R. Kelley Bupropion exposures: clinical manifestations and medical outcome J Emerg Med 23 3 2002 223 230
75. D. Druteika, and P.J. Zed Cardiotoxicity following bupropion overdose Ann Pharmacother 36 11 2002 1791 1795
76. P.A. Paris, and J.R. Saucier ECG conduction delays associated with massive bupropion overdose J Toxicol Clin Toxicol 36 6 1998 595 598
77. B.K.M. Wills, and S. Aks QRS prolongation associated with bupropion ingestion J Toxicol Clin Toxicol 42 5 2004 724
78. D. Blythe, and L.P. Hackett Cardiovascular and neurological toxicity of venlafaxine Hum Exp Toxicol 18 5 1999 309 313
79. K.C.M. Cumpston, and E. Pallasch Massive venlafaxine overdose resulting in arrhythmogenic death J Toxicol Clin Toxicol 41 5 2003 659
80. I.M. Whyte, A.H. Dawson, and N.A. Buckley Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants QJM 96 5 2003 369 374
81. D. Hedges, K. Jeppson, and P. Whitehead Antipsychotic medication and seizures: a review Drugs Today (Barc) 39 7 2003 551 557
82. K.C. Lee, P.R. Finley, and B.K. Alldredge Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings Expert Opin Drug Saf 2 3 2003 233 247
83. J.W. Lee, M.L. Crismon, and P.G. Dorson Seizure associated with olanzapine Ann Pharmacother 33 5 1999 554 556
84. J. Woolley, and S. Smith Lowered seizure threshold on olanzapine Br J Psychiatry 178 1 2001 85 86
85. R.J. Wyderski, W.G. Starrett, and A. Abou-Saif Fatal status epilepticus associated with olanzapine therapy Ann Pharmacother 33 7-8 1999 787 789
86. R.T. Timmer, and J.M. Sands Lithium intoxication J Am Soc Nephrol 10 3 1999 666 674
87. A. Amdisen Clinical features and management of lithium poisoning Med Toxicol Adverse Drug Exp 3 1 1988 18 32
88. B. Kores, and M.H. Lader Irreversible lithium neurotoxicity: an overview Clin Neuropharmacol 20 4 1997 283 299
89. Position paper. Whole bowel irrigation J Toxicol Clin Toxicol 42 6 2004 843 854
90. J.G. Linakis, D.L. Savitt, and T.Y. Wu Use of sodium polystyrene sulfonate for reduction of plasma lithium concentrations after chronic lithium dosing in mice J Toxicol Clin Toxicol 36 4 1998 309 313
91. J.G. Linakis, M.S. Eisenberg, and P.G. Lacouture Multiple-dose sodium polystyrene sulfonate in lithium intoxication: an animal model Pharmacol Toxicol 70 1 1992 38 40
92. R.J. Roberge, T.G. Martin, and S.M. Schneider Use of sodium polystyrene sulfonate in a lithium overdose Ann Emerg Med 22 12 1993 1911 1915
93. J.C. Gehrke, S.M. Watling, and C.W. Gehrke In-vivo binding of lithium using the cation exchange resin sodium polystyrene sulfonate Am J Emerg Med 14 1 1996 37 38
94. A. Jaeger, P. Sauder, and J. Kopferschmitt When should dialysis be performed in lithium poisoning? A kinetic study in 14 cases of lithium poisoning J Toxicol Clin Toxicol 31 3 1993 429 447
95. A.A. Lawson, and D.B. Northridge Dextropropoxyphene overdose. Epidemiology, clinical presentation and management Med Toxicol Adverse Drug Exp 2 6 1987 430 444
96. C.M. Stork, J.T. Redd, and K. Fine Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate - a case report J Toxicol Clin Toxicol 33 2 1995 179 183
97. D.C. Whitcomb, F.R. Gilliam III, and C.F. Starmer Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine J Clin Invest 84 5 1989 1629 1636
98. H. Potschka, E. Friderichs, and W. Loscher Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy Br J Pharmacol 131 2 2000 203 212
99. J.S. Gardner, D. Blough, and C.R. Drinkard Tramadol and seizures: a surveillance study in a managed care population Pharmacotherapy 20 12 2000 1423 1431
100. J.D. Tobias Seizure after overdose of tramadol South Med J 90 8 1997 826 827
101. C. Gasse, L. Derby, and C. Vasilakis-Scaramozza Incidence of first-time idiopathic seizures in users of tramadol Pharmacotherapy 20 6 2000 629 634
102. From the Centers for Disease Control and Prevention Water hemlock poisoning - Maine, 1992 JAMA 271 19 1994 1475
103. K.B. Heath A fatal case of apparent water hemlock poisoning Vet Hum Toxicol 43 1 2001 35 36
104. D. Michelot, and B. Toth Poisoning by Gyromitra esculenta - a review J Appl Toxicol 11 4 1991 235 243
105. C. Karlson-Stiber, and H. Persson Cytotoxic fungi - an overview Toxicon 42 4 2003 339 349
106. US Food and Drug Administration. Consumer alert for ephedrine alkaloids. Available at: http://www.fda.gov. Accessed November 2004.
107. C.A. Haller, and N.L. Benowitz Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids N Engl J Med 343 25 2000 1833 1838
108. A. Tyagi, and N. Delanty Herbal remedies, dietary supplements, and seizures Epilepsia 44 2 2003 228 235
109. E. Perucca, L. Gram, and G. Avanzini Antiepileptic drugs as a cause of worsening seizures Epilepsia 39 1 1998 5 17
110. H.A. Spiller, and R.D. Carlisle Status epilepticus after massive carbamazepine overdose J Toxicol Clin Toxicol 40 1 2002 81 90
111. M.D. Sztajnkrycer Valproic acid toxicity: overview and management J Toxicol Clin Toxicol 40 6 2002 789 801
112. S.M. Singh, B.B. McCormick, and S. Mustata Extracorporeal management of valproic acid overdose: a large regional experience J Nephrol 17 1 2004 43 49
113. J. Sullivan, and G. Krieger Clinical environmental health and toxic exposures 2nd edition 2001 Lippincott Williams & Wilkins Philadelphia
114. Toxicologic profiles ATSDR. Available at: http://www.atsdr.cdc.gov/ toxprofiles. Accessed November 2004.
115. R.S. Hoffman Thallium toxicity and the role of Prussian blue in therapy Toxicol Rev 22 1 2003 29 40
116. F.G. Alvarez, and K.K. Guntupalli Isoniazid overdose: four case reports and review of the literature Intensive Care Med 21 8 1995 641 644
117. E. Boyer Goldfrank's toxicologic emergencies 7th edition 2002 McGraw-Hill New York
118. L.R. Panganiban, I.R. Makalinao, and N.P. Corte-Maramba Rhabdomyolysis in isoniazid poisoning J Toxicol Clin Toxicol 39 2 2001 143 151
119. A.D. Siefkin, T.E. Albertson, and M.G. Corbett Isoniazid overdose: pharmacokinetics and effects of oral charcoal in treatment Hum Toxicol 6 6 1987 497 501
120. N. Scolding, M.J. Ward, and A. Hutchings Charcoal and isoniazid pharmacokinetics Hum Toxicol 5 4 1986 285 286
121. J. Brent, N. Vo, and K. Kulig Reversal of prolonged isoniazid-induced coma by pyridoxine Arch Intern Med 150 8 1990 1751 1753
122. K.A. Santucci, B.R. Shah, and J.G. Linakis Acute isoniazid exposures and antidote availability Pediatr Emerg Care 15 2 1999 99 101
123. C.S. Hornfeldt, and A.A. Larson Adenosine receptors are not involved in theophylline-induced seizures J Toxicol Clin Toxicol 32 3 1994 257 265
124. F.P. Paloucek, and K.A. Rodvold Evaluation of theophylline overdoses and toxicities Ann Emerg Med 17 2 1988 135 144
125. G.M. Glenn, M.S. Krober, and P. Kelly Pyridoxine as therapy in theophylline-induced seizures Vet Hum Toxicol 37 4 1995 342 345
126. T. Sugimoto, M. Sugimoto, and I. Uchida Inhibitory effect of theophylline on recombinant GABA(A) receptor Neuroreport 12 3 2001 489 493
127. F.H. Bahls, K.K. Ma, and T.D. Bird Theophylline-associated seizures with "therapeutic" or low toxic serum concentrations: risk factors for serious outcome in adults Neurology 41 8 1991 1309 1312
128. A. Hoffman, E. Pinto, and D. Gilhar Effect of pretreatment with anticonvulsants on theophylline-induced seizures in the rat J Crit Care 8 4 1993 198 202
129. K.V. Blake, K.L. Massey, and L. Hendeles Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline-induced seizures in mice Ann Emerg Med 17 10 1988 1024 1028
130. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists J Toxicol Clin Toxicol 37 6 1999 731 751
131. C.M. Goetz, G. Lopez, and B.S. Dean Accidental childhood death from diphenhydramine overdosage Am J Emerg Med 8 4 1990 321 322
132. C. Koppel, K. Ibe, and J. Tenczer Clinical symptomatology of diphenhydramine overdose: an evaluation of 136 cases in 1982 to 1985 J Toxicol Clin Toxicol 25 1-2 1987 53 70
133. H.S. Feldman, G.R. Arthur, and B.G. Covino Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog Anesth Analg 69 6 1989 794 801
134. M. Smith, W. Wolfram, and R. Rose Toxicity-seizures in an infant caused by (or related to) oral viscous lidocaine use J Emerg Med 10 5 1992 587 590
135. C.A. Ryan, M. Robertson, and J.Y. Coe Seizures due to lidocaine toxicity in a child during cardiac catheterization Pediatr Cardiol 14 2 1993 116 118
136. A.P. Jonville, P. Barbier, and M.H. Blond Accidental lidocaine overdosage in an infant J Toxicol Clin Toxicol 28 1 1990 101 106
137. P.H. Rosenberg, E.A. Kalso, and M.K. Tuominen Acute bupivacaine toxicity as a result of venous leakage under the tourniquet cuff during a Bier block Anesthesiology 58 1 1983 95 98
138. T. Arai, and K. Kuzume Bupivicaine toxicity and Bier blocks Anesthesiology 59 5 1983 481
139. K. Sawaki, K. Ohno, and K. Miyamoto Effects of anticonvulsants on local anaesthetic-induced neurotoxicity in rats Pharmacol Toxicol 86 2 2000 59 62
140. Y. Momota, A.A. Artru, and K.M. Powers Posttreatment with propofol terminates lidocaine-induced epileptiform electroencephalogram activity in rabbits: effects on cerebrospinal fluid dynamics Anesth Analg 87 4 1998 900 906
141. G. Weinberg, R. Ripper, and D.L. Feinstein Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity Reg Anesth Pain Med 28 3 2003 198 202
142. G.L. Weinberg, T. VadeBoncoeur, and G.A. Ramaraju Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats Anesthesiology 88 4 1998 1071 1075
143. D.N. Ozucelik, O. Karcioglu, and H. Topacoglu Toxicity following unintentional DDT ingestion J Toxicol Clin Toxicol 42 3 2004 299 303
144. S.E. Aks, A. Krantz, and D.O. Hryhrczuk Acute accidental lindane ingestion in toddlers Ann Emerg Med 26 5 1995 647 651
145. T.F. Fischer Lindane toxicity in a 24-year-old woman Ann Emerg Med 24 5 1994 972 974
146. J.T. Kassner, T.J. Maher, and K.M. Hull Cholestyramine as an adsorbent in acute lindane poisoning: a murine model Ann Emerg Med 22 9 1993 1392 1397
147. P.R. Burkhard, K. Burkhardt, and C.A. Haenggeli Plant-induced seizures: reappearance of an old problem J Neurol 246 8 1999 667 670
148. W.J. Phelan III Camphor poisoning: over-the-counter dangers Pediatrics 57 3 1976 428 431
149. J. Strang, W.N. Arnold, and T. Peters Absinthe: what's your poison? Though absinthe is intriguing, it is alcohol in general we should worry about BMJ 319 7225 1999 1590 1592
150. Micromedex Healthcare Series. Poisindex. Available at: http://www.micromedex.com. Accessed November 2004.
151. W.A. Watson, T.L. Litovitz, and W. Klein-Schwartz 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System Am J Emerg Med 22 5 2004 335 404
152. J.H. Trestrail III, and M.E. Spartz Camphorated and castor oil confusion and its toxic results Clin Toxicol 11 2 1977 151 158
153. H.E. Ginn, K.E. Anderson, and R.K. Mercier Camphor intoxication treated by lipid dialysis JAMA 203 3 1968 230 231
154. ACEP Clinical Policies Committee Clinical Policies Subcommittee on Seizures. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures Ann Emerg Med 43 5 2004 605 625
155. B.K. Alldredge, A.M. Gelb, and S.M. Isaacs A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus N Engl J Med 345 9 2001 631 637
156. B.K. Alldredge, D.H. Lowenstein, and R.P. Simon Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures Am J Med 87 6 1989 645 648
157. J.F. Chance Emergency department treatment of alcohol withdrawal seizures with phenytoin Ann Emerg Med 20 5 1991 520 522
158. M.P. Earnest, J.A. Marx, and L.R. Drury Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage JAMA 249 6 1983 762 765
159. B.M. Hodges, and J.E. Mazur Intravenous valproate in status epilepticus Ann Pharmacother 35 11 2001 1465 1470
160. K.T. Yu, S. Mills, and N. Thompson Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures Epilepsia 44 5 2003 724 726
161. P. Kumar, C.J. Vallis, and C.M. Hall Intravenous valproate associated with circulatory collapse Ann Pharmacother 37 12 2003 1797 1799
162. J.R. White, and C.S. Santos Intravenous valproate associated with significant hypotension in the treatment of status epilepticus J Child Neurol 14 12 1999 822 823
163. S. Sinha, and D.K. Naritoku Intravenous valproate is well tolerated in unstable patients with status epilepticus Neurology 55 5 2000 722 724